NTRB
Nutriband Inc.
Biotechnology · Healthcare · United States
6.30
close · 2026-10-30
value
48
cheaper than peers48
quality
29
stronger fundamentals29
ranked against
Biotechnology (commercial)
value
quality
162 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, 3 years ago | -8.4% | 67 |
| cash flow yield, 3 years ago | -4.0% | 64 |
| cash flow yield, 2 years ago | -4.7% | 64 |
| cash flow yield, 1 year ago | -6.2% | 62 |
| earnings yield, 2 years ago | -11.0% | 59 |
| cash flow yield, latest year | -6.7% | 58 |
| earnings yield, 1 year ago | -15.7% | 50 |
| earnings yield, latest year | -41.0% | 26 |
| price to sales | 42.48× | 25 |
| price to book | 14.38× | 15 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 3.9% | 78 |
| operating margin | -289.4% | 41 |
| revenue growth | -35.1% | 23 |
| return on equity | -145.7% | 16 |
4 of 4 measures available
Facts
| market cap | $77M |
| free cash flow | -$1.7M |
| employees | none reported |
| first trade | 2021-10-01 |
| next earnings | not reported |
| fundamentals updated | 2026-08-21 |
Annual history
| measure | 2026 | 2025 | 2024 | 2023 |
| diluted eps | -2.58 | -0.99 | -0.69 | -0.53 |
| free cash flow | -$5.1M | -$4.7M | -$3.6M | -$3.1M |
| net income | -$8.2M | -$10.5M | -$5.5M | -$4.5M |
| revenue | $2.0M | $2.1M | $2.1M | $2.1M |
| unusual items | $0 | -$4.0M | -$554,423 | -$327,326 |